You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CLDI Award Disclosure
Fernandez Santidrian Antonio · SEC Form 4 · Filed Aug 19, 2026
Award
Reported value range
Not reported
Fernandez Santidrian Antonio Chief Scientific Officer
CLDI
Transaction date
Aug 17, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 2 days later
CLDI daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (right to buy) on Common stock
- Quantity / price
- 16,000 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-039286
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Calidi Biotherapeutics, Inc. CLDI Current | Award | Aug 17, 2026 | Not reported |